|
| 36049896 | Expanded Clinical Pharmacogenetics Implementation Consortium Guideline for Medication Use in the Context of G6PD Genotype. | Clin Pharmacol Ther | 2023 |
| 37669183 | PharmVar Tutorial on CYP2D6 Structural Variation Testing and Recommendations on Reporting. | Clin Pharmacol Ther | 2023 |
| 37757824 | Frequencies of pharmacogenomic alleles across biogeographic groups in a large-scale biobank. | Am J Hum Genet | 2023 |
| 37728645 | PharmGKB summary: disulfiram pathway. | Pharmacogenet Genomics | 2023 |
| 35797228 | PharmVar GeneFocus: SLCO1B1. | Clin Pharmacol Ther | 2023 |
| 37165881 | The Role of Epigenomics in Mapping Potential Precursors for Foot and Ankle Tendinopathy: A Systematic Review. | Foot Ankle Spec | 2023 |
| 37032427 | Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6, CYP2C19, CYP2B6, SLC6A4, and HTR2A Genotypes and Serotonin Reuptake Inhibitor Antidepressants. | Clin Pharmacol Ther | 2023 |
| 36350094 | How to Run the Pharmacogenomics Clinical Annotation Tool (PharmCAT). | Clin Pharmacol Ther | 2023 |
| 34032273 | Clinical Pharmacogenetics Implementation Consortium Guideline for the Use of Aminoglycosides Based on MT-RNR1 Genotype. | Clin Pharmacol Ther | 2022 |
| 35802134 | ACMG SF v3.1 list for reporting of secondary findings in clinical exome and genome sequencing: A policy statement of the American College of Medical Genetics and Genomics (ACMG). | Genet Med | 2022 |
| 35665708 | PharmGKB summary: acyclovir/ganciclovir pathway. | Pharmacogenet Genomics | 2022 |
| 36443877 | Evaluating the frequency and the impact of pharmacogenetic alleles in an ancestrally diverse Biobank population. | J Transl Med | 2022 |
| 35102073 | PharmGKB summary: heparin-induced thrombocytopenia pathway, adverse drug reaction. | Pharmacogenet Genomics | 2022 |
| 34890165 | An Investigation of the Knowledge Overlap between Pharmacogenomics and Disease Genetics. | Pac Symp Biocomput | 2022 |
| 35152405 | The Clinical Pharmacogenetics Implementation Consortium Guideline for SLCO1B1, ABCG2, and CYP2C9 genotypes and Statin-Associated Musculoskeletal Symptoms. | Clin Pharmacol Ther | 2022 |
| 35034351 | Clinical Pharmacogenetics Implementation Consortium Guideline for CYP2C19 Genotype and Clopidogrel Therapy: 2022 Update. | Clin Pharmacol Ther | 2022 |
| 35177334 | Clinical pharmacogenomic testing and reporting: A technical standard of the American College of Medical Genetics and Genomics (ACMG). | Genet Med | 2022 |
| 35202484 | PharmVar GeneFocus: CYP3A5. | Clin Pharmacol Ther | 2022 |
| 32779747 | Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2C9 and HLA-B Genotypes and Phenytoin Dosing: 2020 Update. | Clin Pharmacol Ther | 2021 |
| 33627827 | Expanding evidence leads to new pharmacogenomics payer coverage. | Genet Med | 2021 |
| 34387941 | PharmGKB, an Integrated Resource of Pharmacogenomic Knowledge. | Curr Protoc | 2021 |
| 34216021 | An Evidence-Based Framework for Evaluating Pharmacogenomics Knowledge for Personalized Medicine. | Clin Pharmacol Ther | 2021 |
| 34345026 | Correction to: ACMG SF v3.0 list for reporting of secondary findings in clinical exome and genome sequencing: a policy statement of the American College of Medical Genetics and Genomics (ACMG). | Genet Med | 2021 |
| 34012069 | Recommendations for reporting of secondary findings in clinical exome and genome sequencing, 2021 update: a policy statement of the American College of Medical Genetics and Genomics (ACMG). | Genet Med | 2021 |
| 34012068 | ACMG SF v3.0 list for reporting of secondary findings in clinical exome and genome sequencing: a policy statement of the American College of Medical Genetics and Genomics (ACMG). | Genet Med | 2021 |
| 34091888 | Pharmacogene Variation Consortium: A Global Resource and Repository for Pharmacogene Variation. | Clin Pharmacol Ther | 2021 |
| 34109627 | PharmVar GeneFocus: CYP2C9. | Clin Pharmacol Ther | 2021 |
| 33252176 | Verifying nomenclature of DNA variants in submitted manuscripts: Guidance for journals. | Hum Mutat | 2021 |
| 33448339 | PharmVar GeneFocus: CYP2B6. | Clin Pharmacol Ther | 2021 |
| 33237584 | Pharmacogenetics at Scale: An Analysis of the UK Biobank. | Clin Pharmacol Ther | 2021 |
| 33070160 | Pharmacogenetic information in Swiss drug labels - a systematic analysis. | Pharmacogenomics J | 2021 |
| 33387367 | Clinical Pharmacogenetics Implementation Consortium Guideline for CYP2D6, OPRM1, and COMT Genotypes and Select Opioid Therapy. | Clin Pharmacol Ther | 2021 |
| 33147643 | Review and Consensus on Pharmacogenomic Testing in Psychiatry. | Pharmacopsychiatry | 2021 |
| 32770672 | Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2C19 and Proton Pump Inhibitor Dosing. | Clin Pharmacol Ther | 2021 |
| 32602114 | PharmVar GeneFocus: CYP2C19. | Clin Pharmacol Ther | 2021 |
| 32978778 | PharmGKB Tutorial for Pharmacogenomics of Drugs Potentially Used in the Context of COVID-19. | Clin Pharmacol Ther | 2021 |
| 31504375 | Pharmacogenomic polygenic response score predicts ischaemic events and cardiovascular mortality in clopidogrel-treated patients. | Eur Heart J Cardiovasc Pharmacother | 2020 |
| 31758698 | PharmVar and the Landscape of Pharmacogenetic Resources. | Clin Pharmacol Ther | 2020 |
| 31647186 | Standardizing CYP2D6 Genotype to Phenotype Translation: Consensus Recommendations from the Clinical Pharmacogenetics Implementation Consortium and Dutch Pharmacogenetics Working Group. | Clin Transl Sci | 2020 |
| 31664715 | A Call for Clear and Consistent Communications Regarding the Role of Pharmacogenetics in Antidepressant Pharmacotherapy. | Clin Pharmacol Ther | 2020 |
| 31797632 | PGxMine: Text mining for curation of PharmGKB. | Pac Symp Biocomput | 2020 |
| 31851125 | PharmGKB summary: sertraline pathway, pharmacokinetics. | Pharmacogenet Genomics | 2020 |
| 31851124 | PharmGKB summary: very important pharmacogene information for CACNA1S. | Pharmacogenet Genomics | 2020 |
| 32932966 | Effect of <i>CYP3A4</i>*22 and <i>PPAR-α</i> Genetic Variants on Platelet Reactivity in Patients Treated with Clopidogrel and Lipid-Lowering Drugs Undergoing Elective Percutaneous Coronary Intervention. | Genes (Basel) | 2020 |
| 32189324 | Clinical Pharmacogenetics Implementation Consortium Guideline (CPIC) for CYP2C9 and Nonsteroidal Anti-Inflammatory Drugs. | Clin Pharmacol Ther | 2020 |
| 32187155 | PharmGKB summary: lamotrigine pathway, pharmacokinetics and pharmacodynamics. | Pharmacogenet Genomics | 2020 |
| 32472697 | Genomewide Association Study of Platelet Reactivity and Cardiovascular Response in Patients Treated With Clopidogrel: A Study by the International Clopidogrel Pharmacogenomics Consortium. | Clin Pharmacol Ther | 2020 |
| 32407955 | Response to: Unveiling the guidance heterogeneity for genome-informed drug treatment interventions among regulatory bodies and research consortia. | Pharmacol Res | 2020 |
| 31544239 | PharmVar GeneFocus: CYP2D6. | Clin Pharmacol Ther | 2020 |
| 31306493 | Pharmacogenomics Clinical Annotation Tool (PharmCAT). | Clin Pharmacol Ther | 2020 |